Tyra Biosciences, Inc. Common Stock TYRA
$28.65
+15.25%
at last close
Analyst Consensus
- Consensus Rating
- Buy (11 Buy · 1 Hold · 0 Sell)
- Average Price Target
- $50.80
- Implied Upside
- +77.3%
- Price Target Range
- $42.00 – $59.00
- Analysts (12 mo)
- 12
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-09-04 | HC Wainwright & Co.Mitchell S. Kapoor |
Reiterates | Buy | $45 |
| 2026-06-17 | Jones TradingMatthew Murray |
Initiates coverage on | Buy | $56 |
| 2026-06-10 | B of A SecuritiesGeoff Meacham |
Maintains | Buy | $37 → $42 |
| 2026-05-19 | Wolfe ResearchKalpit Patel |
Initiates coverage on | Peer perform | — |
| 2026-05-14 | HC Wainwright & Co.Mitchell S. Kapoor |
Reiterates | Buy | $45 |
| 2026-04-15 | GuggenheimBrad Canino |
Initiates coverage on | Buy | $54 |
| 2026-04-06 | Canaccord GenuityJohn Newman |
Initiates coverage on | Buy | $50 |
| 2026-03-20 | Piper SandlerAllison Bratzel |
Maintains | Overweight | $42 → $56 |
| 2026-02-24 | Cantor FitzgeraldLi Watsek |
Initiates coverage on | Overweight | — |
| 2026-02-17 | HC Wainwright & Co.Mitchell S. Kapoor |
Maintains | Buy | $30 → $45 |
| 2026-02-13 | WedbushRobert Driscoll |
Maintains | Outperform | $37 → $53 |
| 2026-02-03 | OppenheimerMatthew Biegler |
Maintains | Outperform | $36 → $50 |
| 2026-02-03 | JefferiesMaury Raycroft |
Maintains | Buy | $32 → $43 |
| 2026-01-28 | BarclaysEliana Merle |
Initiates coverage on | Overweight | $59 |
| 2026-01-23 | Piper SandlerAllison Bratzel |
Maintains | Overweight | $33 → $42 |
| 2025-12-16 | WedbushRobert Driscoll |
Maintains | Outperform | $30 → $37 |
| 2025-09-03 | Raymond JamesChris Raymond |
Initiates coverage on | Strong buy | $35 |
| 2025-08-22 | HC Wainwright & Co.Mitchell S. Kapoor |
Reiterates | Buy | $30 |
| 2025-07-01 | HC Wainwright & Co.Mitchell Kapoor |
Reiterates | Buy | $30 |
| 2025-05-21 | Piper SandlerAllison Bratzel |
Assumes | Overweight | $33 |
| 2025-03-31 | HC Wainwright & Co.Mitchell Kapoor |
Reiterates | Buy | $30 |
| 2025-02-18 | HC Wainwright & Co.Mitchell Kapoor |
Reiterates | Buy | $30 |
| 2025-01-13 | HC Wainwright & Co.Mitchell Kapoor |
Reiterates | Buy | $30 |
| 2025-01-07 | UBSEliana Merle |
Initiates coverage on | Buy | $28 |
| 2024-11-11 | HC Wainwright & Co.Mitchell Kapoor |
Maintains | Buy | $32 → $30 |
| 2024-10-29 | HC Wainwright & Co.Mitchell Kapoor |
Reiterates | Buy | $32 |
| 2024-10-28 | HC Wainwright & Co.Mitchell Kapoor |
Maintains | Buy | $30 → $32 |
| 2024-10-25 | WedbushRobert Driscoll |
Reiterates | Outperform | $28 |
| 2024-10-18 | B of A SecuritiesGeoff Meacham |
Upgrades | Neutral → Buy | $22 → $31 |
| 2024-10-07 | HC Wainwright & Co.Mitchell Kapoor |
Maintains | Buy | $25 → $30 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $28.65
- Market Cap
- $1.71 billion
- 52-Week Range
- $9.96 – $40.65
- Average Volume
- 604K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.